knowledge | a-connect

AGILE – The art of adapting to change and innovation

Increasing complexity and the pace of change requires a new mindset and approach to leadership

Patients not patents – new times spell new solutions for the pharma industry

As pharma redefines itself in the digital age, companies all over the world are setting their sights on new target groups

Blockchain-ing the Money Machine

How the technology that powers bitcoin can reshape the financial services landscape

Who’s afraid of the robo-consultant?

Around 66% of Americans believe that artificial intelligence (AI) will soon replace most of the work that is currently completed by humans.

From PowerPoint to bottom line

Supercharging your implementation efforts to deliver on the promise of your strategy

filter by

“Brexit means Brexit”—but what will it mean for pharmaceutical market access?

Part 3: Is there a silver lining to this cloud? - a guest article from Neil Grubert

29 August 2016

What’s driving the demand for the open talent economy?

how supply drivers, demand drivers, demographic trends and structural changes are shaping the Future of Work.

25 August 2016

“Brexit means Brexit”—but what will it mean for pharmaceutical market access?

Part 2: What will happen before and after Brexit? - a guest article from Neil Grubert

22 August 2016

Challenges and opportunities of the open talent economy

Read about how the on-demand workforce is impacting companies and independent professionals.

17 August 2016

“Brexit means Brexit”—but what will it mean for pharmaceutical market access?

Part 1: Why does it matter? - a guest article from Neil Grubert

16 August 2016

Perspectives on CSR – a-connect insights from a recent diagnostic project at a Fortune 500 client

Read about CSR best-practices and how corporations apply them.

28 July 2016

a-connect tags

All

join the discussion on join the discussion on

Today, no company can afford to ignore CSR

how investors, customers, civil parties and employees call for companies to act and how they can incorporate CSR and sustainability within their core business. A guest article from Manuela Drews.

28 July 2016

< 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 >

Industry

Business Functions

AGILE – The art of adapting to change and innovation

Patients not patents – new times spell new solutions for the pharma industry

Blockchain-ing the Money Machine

Who’s afraid of the robo-consultant?

From PowerPoint to bottom line

“Brexit means Brexit”—but what will it mean for pharmaceutical market access?

What’s driving the demand for the open talent economy?

“Brexit means Brexit”—but what will it mean for pharmaceutical market access?

Challenges and opportunities of the open talent economy

“Brexit means Brexit”—but what will it mean for pharmaceutical market access?

Perspectives on CSR – a-connect insights from a recent diagnostic project at a Fortune 500 client

a-connect tags

Today, no company can afford to ignore CSR

request a call back

a-connect linkedin profile

a-connect

latest on twitter